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Abstract: 
Purpose: To evaluate the demographic and clinical manifestations and postsurgical outcome of 
childhood-onset mesial temporal sclerosis and temporal lobe epilepsy (MTS-TLE) and 
establishing the potential differences as compared to the patients with adult-onset MTS-TLE.  
Method: In this retrospective study all patients with a clinical diagnosis of medically refractory 
TLE due to mesial temporal sclerosis, who underwent epilepsy surgery at Jefferson 
comprehensive epilepsy center, were recruited.  Patients were prospectively registered in a 
database from 1986 through 2014. Post-surgical outcome was classified into two groups; seizure-
free or relapsed. Clinical manifestations and outcome were compared between patients with 
childhood-onset MTS-TLE (i.e., age at onset of the first afebrile habitual seizure below 10 years) 
and those with adult-onset MTS-TLE (i.e., age at onset of the first afebrile habitual seizure 20 
years or above). 
Results: One hundred and twelve patients had childhood-onset MTS-TLE and 76 had adult-
onset MTS-TLE. Demographic, clinical, EEG and MRI characteristics of these two groups were 
similar. Postoperative outcome was not statistically different between these two groups of 
patients (P = 0.9). 
Conclusion: Temporal lobe epilepsy due to mesial temporal sclerosis is a common cause of 
epilepsy that can start from early childhood to late adulthood. The etiology of MTS-TLE may be 
different in various age groups, but it seems that when mesial temporal sclerosis is the 
pathological substrate of TLE, clinical manifestations and response to surgical treatment of 
patients are very similar in patients with childhood-onset MTS-TLE compared to those with 
adult-onset disease. 
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Introduction 
Focal epilepsies account for about two-thirds of all adult epilepsy patients, and temporal lobe 
epilepsy (TLE) is the most common type of focal epilepsy 1, 2. Mesial temporal sclerosis (MTS) 
is the most common pathological substrate of TLE 3. Temporal lobe epilepsy (TLE) with MTS is 
one of the most common types of medically-refractory epilepsy referred for epilepsy surgery; it 
is often refractory to antiepileptic drugs (AEDs), but responds favorably to surgery 1, 4. 
In children, MTS is considered an infrequent etiology of epilepsy, but with the advances 
in diagnostic technologies, it has started to be diagnosed at an increasingly younger ages 5, 6. 
Besides, even in many adults with MTS-TLE a detailed clinical history will clarify that the age at 
onset of the habitual seizures was in childhood 7. It has been previously reported that, older age 
at onset of epilepsy predicts better prognosis in patients with TLE 8. 
The aim of this study was to evaluate the demographic and clinical manifestations of 
childhood-onset MTS-TLE and establishing the potential differences as compared to 
manifestations observed in adult-onset MTS-TLE. We also investigated the surgery outcome in 
childhood-onset MTS-TLE in comparison with that in adult-onset MTS-TLE. 
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Methods  
In this retrospective study all patients with a clinical diagnosis of medically refractory TLE due 
to mesial temporal sclerosis, who underwent epilepsy surgery at Jefferson comprehensive 
epilepsy center, were recruited.  Patients were prospectively registered in a database from 1986 
through 2014. The diagnosis of MTS-TLE was made by the epileptologists working at this 
institution and based on clinical grounds (semiology), electroencephalographic (EEG) findings 
and imaging [magnetic resonance imaging (MRI)]. There was no age limit to enter the study. For 
all patients, a comprehensive presurgical evaluation including a 1.5 Tesla brain MRI (epilepsy 
protocol) was performed. Magnetic resonance imaging studies were analyzed by 
neuroradiologists with expertise in epilepsy. Electroencephalographic (EEG) localization was 
considered unilateral if interictal and ictal EEG findings pointed to one side and considered as 
bilateral if either interictal or ictal EEG was bilateral or they were discordant. We classified 
patients as having childhood-onset MTS-TLE, if the age at onset of the first afebrile habitual 
seizure was below 10 years and adult-onset MTS-TLE, if the age at onset of the first afebrile 
habitual seizure was 20 years or above. We classified patients as having MTS if they had clear 
signs of mesial temporal atrophy and/or sclerosis in their MRI. Patients with normal MRI and 
those with dual pathology were excluded from this study.  
All patients were submitted to surgical treatment (i.e., anterior temporal lobectomy). 
They all had to be under the care of an epileptologist at our institution for at least one year, 
postoperatively. They were followed for up to five years after their surgery. Post-surgical 
outcome was classified into two groups; seizure-free or relapsed. Aura was not considered as a 
relapse; only postoperative tonic-clonic seizures and complex partial seizures were considered as 
relapse.  
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Age, gender, race, epilepsy risk factors (e.g., febrile seizure, family history of epilepsy, 
etc.), age at seizure onset (i.e., the first afebrile habitual seizure), seizure type(s), EEG findings 
and MRI findings, date of surgery, date of the first relapse (if any) and date of the last contact 
with all patients were registered routinely. 
Demographic variables and relevant clinical variables were summarized descriptively to 
characterize the study population. All variables were compared between patients with childhood-
onset versus those with adult-onset MTS-TLE. Pearson Chi-Square, Fisher’s Exact, Mantel-Cox 
and t- test were used for statistical analyses. Time to event analysis was used to produce a 
Kaplan-Meier estimate of seizure recurrence. Odds ratio and 95% confidence interval (CI) were 
calculated. P value less than 0.05 was considered as significant. This study was conducted with 
the approval by Thomas Jefferson University Review Board. 
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Results 
Two-hundred eighty-one patients in our database had MTS-TLE with at least one year of 
postoperative follow-up. Age at onset of their habitual afebrile seizures is shown in figure 1. One 
hundred and eighty-eight patients were eligible for this study (89 males and 99 females). One 
hundred and twelve patients had childhood-onset MTS-TLE and 76 had adult-onset MTS-TLE. 
Demographic characteristics of these two groups are shown and compared in table 1. Clinical 
characteristics of these two groups are shown and compared in table 2. Odds ratio of having 
history febrile seizures in patients with childhood-onset MTS-TLE compared to those with adult 
onset disease was 3.1 (95% CI: 1.6-6). Electroencephalographic (EEG) characteristics of these 
two groups are shown and compared in table 3. The EEG localization of the epileptogenic zone 
was not differently distributed in these two groups of patients (P = 0.2). Imaging (MRI) 
characteristics of these two groups are shown and compared in table 4. The MRI localization of 
the epileptogenic zone was not differently distributed in these two groups of patients (P = 0.07). 
Finally, postoperative outcome was not statistically different between these two groups of 
patients (P = 0.9) (Figure 2). The duration of postoperative follow-up was 4.2 ± 1.2 years in the 
first group and 4 ± 1.4 years in the second group; it was not statistically different between these 
two groups (P = 0.2). Epilepsy duration before surgery in patients with childhood-onset disease 
was 30 ± 12 years and in those with adult-onset epilepsy was 13 ± 9 years (P = 0.0001). 
However, this is a biased comparison as we had already dichotomized the patients based on their 
age at the disease onset. 
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Discussion 
Mesial temporal sclerosis is a major etiology for epilepsy in adult populations, but it has been 
reported to be an uncommon finding in children with epilepsy 9. However, there is enough 
evidence to conclude that the age at onset of habitual seizures in MTS-TLE is earlier compared 
to that for TLE due to other etiologies; it is often in childhood or early adolescence 7. In our 
study, age at onset of MTS-TLE was in childhood (i.e., below 10 years of age) in 39.8% of the 
patients. Therefore, the syndrome of MTS-TLE is not rare and may be identified adequately even 
in young children 10. But, adult onset MTS-TLE was not uncommon either and in 27% of 
patients the age at onset of habitual seizures was in their adulthood (i.e., 20 years or above).  
Interestingly, demographic and clinical manifestations of medically-refractory temporal 
lobe epilepsy and mesial temporal sclerosis were very similar between patients with childhood-
onset and those with adult-onset disease, in our study. The syndrome of MTS-TLE in childhood 
often presents with a different semiology compared with that in adults, which is strongly related 
to brain maturation and neuropsychological development 10. Aura is rarely observed in very 
young children, probably because they are not able to describe their subjective feelings. 
However, when children grow, their semiology becomes similar to that in adults. In our study, 
age at surgery spanned from 12 to 68 years, so the youngest patient had a mature brain and was 
already grown enough to describe his symptoms. We observed that, not only the seizure types, 
but also the types of auras that patients experienced were similar between patients with 
childhood-onset and those with adult-onset disease. Even, electroencephalography or imaging 
findings were very similar between these two groups of patients. 
With regard to surgery outcome, patients with childhood-onset MTS-TLE and those with 
adult-onset disease fared almost similarly and both groups responded well to epilepsy surgery. In 
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a previous study of surgery for temporal lobe epilepsy with hippocampal involvement in 
preadolescent children 11, outcomes at the last follow-up examination were categorized as Engel 
Class I-II in 20 (76.9%) of 26 children with confirmed MTS, which is comparable to adult 
studies. This finding is in contrast with the findings in a previous study, in which 190 patients 
with TLE were analyzed and older age at onset predicted better post-surgical prognosis 8. 
However, their inclusion criteria were different from ours, as they included patients with normal 
MRI in addition to those with MTS. Besides, they excluded those with family history of TLE and 
we did not. Their end point was time to 24 month seizure freedom after surgery.  
One significant difference that we observed between patients with childhood-onset MTS-
TLE and those with adult-onset disease was higher frequent of history of childhood febrile 
convulsions in the former group. The frequency of febrile convulsions was more than twice in 
patients with childhood-onset MTS-TLE compared to those with adult-onset MTS-TLE. This 
increased frequency of febrile convulsions in patients with childhood-onset MTS-TLE might be 
partly due to reporting bias (e.g., parents were present at the interview and febrile convulsion 
happened more recently). However, there is evidence that prolonged febrile seizures may cause 
hippocampal changes. In one study, MRI findings of a markedly hyperintense hippocampus in 
children with febrile status epilepticus was highly associated with subsequent mesial temporal 
sclerosis 12. There is also evidence that suggests a subtle, pre-existing hippocampal malformation 
may exist in some patients that may facilitate febrile convulsions and contribute to the 
development of subsequent MTS 13. In any way, the observed difference of frequency of history 
of febrile convulsions between patients with childhood-onset MTS-TLE and those with adult-
onset disease may suggest that the cause of MTS-TLE could be different in these two groups of 
patients. This should be explored in future studies.  
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Conclusions 
Temporal lobe epilepsy due to mesial temporal sclerosis is a common cause of epilepsy that can 
start from early childhood to late adulthood. The etiology of medically-refractory MTS-TLE may 
be different in various age groups, but it seems that when mesial temporal sclerosis is the only 
detectable pathological substrate of TLE, clinical manifestations and response to surgical 
treatment of patients are very similar in childhood-onset MTS-TLE compared to those with 
adult-onset disease. 
 
Study limitations 
This was a clinic-based series of patients with medically-refractory MTS-TLE and may not 
represent the full spectrum of MTS-TLEs. Besides, this study was retrospective and uncontrolled 
in design. Lastly, epilepsy duration may be considered as a confounder in this study. However, it 
could have been true if the outcome results were different in those two groups of patients. 
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Figure 1 legend. Mean age at onset of all 281 patients was 15 ± 13 years. Minimum age 
at onset was the neonatal period and maximum age was 64 years.  
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Figure 2 legend. Postoperative outcome was not statistically different between these two 
groups of patients (P = 0.9). 
